Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             42 results found
no title author magazine year volume issue page(s) type
1 A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder Hanssens, Linda
2008
106 2-3 p. 308-314
7 p.
article
2 A diffusion tensor MRI study of white matter integrity in subjects at high genetic risk of schizophrenia Muñoz Maniega, S.
2008
106 2-3 p. 132-139
8 p.
article
3 A DTI study of white matter microstructure in individuals at high genetic risk for schizophrenia Hoptman, Matthew J.
2008
106 2-3 p. 115-124
10 p.
article
4 Altered interleukin-3 serum levels in drug-naïve and neuroleptic-treated schizophrenic patients Xiu, Mei Hong
2008
106 2-3 p. 369-370
2 p.
article
5 Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia Shirts, Brian H.
2008
106 2-3 p. 268-274
7 p.
article
6 A self-reported instrument for prodromal symptoms of psychosis: Testing the clinical validity of the PRIME Screen—Revised (PS-R) in a Japanese population Kobayashi, Hiroyuki
2008
106 2-3 p. 356-362
7 p.
article
7 Association between a disrupted-in-schizophrenia 1 (DISC1) single nucleotide polymorphism and schizophrenia in a combined Scandinavian case–control sample Saetre, Peter
2008
106 2-3 p. 237-241
5 p.
article
8 Association of Sult4A1 SNPs with psychopathology and cognition in patients with schizophrenia or schizoaffective disorder Meltzer, Herbert Y.
2008
106 2-3 p. 258-264
7 p.
article
9 Basic helix–loop–helix transcription factor NEUROG1 and schizophrenia: Effects on illness susceptibility, MRI brain morphometry and cognitive abilities Ho, Beng-Choon
2008
106 2-3 p. 192-199
8 p.
article
10 Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine Newcomer, John W.
2008
106 2-3 p. 300-307
8 p.
article
11 Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging Bose, Subrata K.
2008
106 2-3 p. 148-155
8 p.
article
12 Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia Feng, Ya-Qin
2008
106 2-3 p. 218-228
11 p.
article
13 Editorial Board 2008
106 2-3 p. IFC-
1 p.
article
14 Effects of mental illness and aging in two thalamic nuclei Byne, William
2008
106 2-3 p. 172-181
10 p.
article
15 Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia Smith, Matthew J.
2008
106 2-3 p. 294-299
6 p.
article
16 Elevated serum levels of tumor necrosis factor-α in clozapine-associated obesity in chronic schizophrenia Chen, Da Chun
2008
106 2-3 p. 367-368
2 p.
article
17 Erratum to ‘Letter to the Editor “Subclinical expression of schizophrenia-like symptoms in non-psychotic siblings of individuals with schizophrenia” [Schizophrenia Research 103 (2008) 324–325] Smith, M.J.
2008
106 2-3 p. 374-
1 p.
article
18 Evidence for reduced neuronal somal size within the insular cortex in schizophrenia, but not in affective disorders Pennington, K.
2008
106 2-3 p. 164-171
8 p.
article
19 Frequency of abnormal correlation between leptin and the body mass index during first and second generation antipsychotic drug treatment Peña, Rocio
2008
106 2-3 p. 315-319
5 p.
article
20 Frontal release signs among patients with schizophrenia, their first-degree biological relatives, and non-psychiatric controls Gabalda, Megan K.
2008
106 2-3 p. 275-280
6 p.
article
21 Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia Zai, Clement C.
2008
106 2-3 p. 248-252
5 p.
article
22 Geographic variation and sociodemographic characteristics of psychotic disorders in Finland Perälä, Jonna
2008
106 2-3 p. 337-347
11 p.
article
23 Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia Edwards, Todd L.
2008
106 2-3 p. 208-217
10 p.
article
24 Is the histidine triad nucleotide-binding protein 1 (HINT1) gene a candidate for schizophrenia? Chen, Qi
2008
106 2-3 p. 200-207
8 p.
article
25 Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy Ohrmann, Patricia
2008
106 2-3 p. 156-163
8 p.
article
26 Levels of [3H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1 Dean, Brian
2008
106 2-3 p. 229-236
8 p.
article
27 Neurocognitive functioning and facial affect recognition in treatment-resistant schizophrenia treated with clozapine Machado de Sousa, João Paulo
2008
106 2-3 p. 371-372
2 p.
article
28 Novel rating scales for schizophrenia — Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz) Suzuki, Takefumi
2008
106 2-3 p. 328-336
9 p.
article
29 Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study Goff, Donald C.
2008
106 2-3 p. 320-327
8 p.
article
30 Outcome after discharge from an early psychosis program Addington, Jean
2008
106 2-3 p. 363-366
4 p.
article
31 Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse Zhang, Yanbo
2008
106 2-3 p. 182-191
10 p.
article
32 Reduced interhemispheric connectivity in schizophrenia-tractography based segmentation of the corpus callosum Kubicki, M.
2008
106 2-3 p. 125-131
7 p.
article
33 Reductions in frontal, temporal and parietal volume associated with the onset of psychosis Borgwardt, Stefan J.
2008
106 2-3 p. 108-114
7 p.
article
34 Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia Ballmaier, Martina
2008
106 2-3 p. 140-147
8 p.
article
35 Schizophrenia, “just the facts”: What we know in 2008 Keshavan, Matcheri S.
2008
106 2-3 p. 89-107
19 p.
article
36 Sequence analysis of P21-activated kinase 3 (PAK3) in chronic schizophrenia with cognitive impairment Morrow, Eric M.
2008
106 2-3 p. 265-267
3 p.
article
37 Subjective reasons for adherence to psychotropic medication and associated factors among older adults with schizophrenia Sapra, Mamta
2008
106 2-3 p. 348-355
8 p.
article
38 Successful acamprosate treatment of alcohol dependence in schizophrenia Tek, Cenk
2008
106 2-3 p. 373-
1 p.
article
39 Symptom remission in first episode patients Addington, Jean
2008
106 2-3 p. 281-285
5 p.
article
40 Telomerase levels in schizophrenia: A preliminary study Porton, Barbara
2008
106 2-3 p. 242-247
6 p.
article
41 Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis Corcoran, Cheryl M.
2008
106 2-3 p. 286-293
8 p.
article
42 The epsin 4 gene is associated with psychotic disorders in families of Latin American origin Escamilla, Michael
2008
106 2-3 p. 253-257
5 p.
article
                             42 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands